West Pharmaceutical Services | WST - Ebitda


West Pharmaceutical Services reported $226.2M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Align Technology USD 260.87M 77.03M Dec/2025
Avanos Medical USD 13M 3M Dec/2025
Baxter International USD -447M 873M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
Dentsply International USD 129M 6M Mar/2026
Haemonetics USD 94.78M 20.75M Dec/2025
ICU Medical USD 98.68M 489K Mar/2026
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
IQVIA Holdings USD 932M 114M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Neogen USD 48.2M 546K Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quidel USD 108.7M 44.6M Mar/2026
Repligen USD 40.01M 469K Mar/2026
Solventum Corp USD 437M 0 Mar/2026
STAAR Surgical USD -159K 34.78M Dec/2025
Terumo JPY 57.88B 12.1B Mar/2026
West Pharmaceutical Services USD 226.2M 7.7M Mar/2026